Siddhivinayak Trust to provide Rs 10 crore for pneumococcal vaccination drive

Published On 2019-12-29 03:50 GMT   |   Update On 2019-12-29 03:50 GMT

The Shree Siddhivinayak Ganapati Temple Trust has sanctioned Rs 10 crore for the Maharashtra government’s drive of giving pneumococcal vaccines to the children in tribal areas of the state.


Mumbai: The vaccination will be carried out in Nandurbar, Palghar, Gadchiroli, Amravati and Nashik for 1.41 lakh children in the age group of 0-1 year


The Shree Siddhivinayak Ganapati Temple Trust has sanctioned Rs 10 crore for the Maharashtra government’s drive of giving pneumococcal vaccines to the children in tribal areas of the state.


Chairman of the Trust, Aadesh Bandekar, said this in a statement issued in Mumbai.


‘Of the 16 tribal-dominated districts in the state, the first phase of the vaccination will be carried out in Nandurbar, Palghar, Gadchiroli, Amravati and Nashik for 1.41 lakh children in the age group of 0-1 years,’ he said.


Read Also: Panacea Biotec wins Rs 170 crore Pentavalent vaccine orders from UN agencies


‘The vaccine has to be given three times before a child completes nine months. In these five districts, 4.62 lakh vaccine doses are required,’ he said adding that the Trust will provide Rs 10 crore for the purpose.


The vaccination will help reduce the incidence of pneumonia among the tribal children, the statement said.


Read Also: Merck Ebola vaccine Ervebo to be available at a lowest access price for poor nations

Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News